Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +20.08%
#3 Fake World Assets Fake World Assets +8.58%
#4 Status Status +8.22%
#5 Pons Pons +6.97%
#6 Ribbita by Virtuals Ribbita by Virtuals +6.85%
#7 would would +6.62%
#8 WAX WAX +6.52%
#9 edgeX edgeX +6.10%
#10 Hive Hive +4.94%
Coin of the day
Palladium Network Palladium Network
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Kedudukan dalam Saham #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Harga Saham
$5.84
Disegerakkan terakhir: 2025-04-02
Modal Pasaran
$224.09M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Nevro Corp. (NVRO)

Kategori

Healthcare
Nisbah P/E bagi Nevro Corp. (NVRO)
Nisbah P/E pada September 2026 TTM: -1.91
Menurut laporan kewangan dan harga saham terkini Nevro Corp., nisbah P/E semasa (TTM) ialah -1.91. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -8.40.
Sejarah nisbah P/E bagi Nevro Corp. dari 2012 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -1.91 56.43%
2024 -1.22 -85.52%
2023 -8.40 -101.80%
2022 466.04 -2,268.47%
2021 -21.49 -69.38%
2020 -70.18 100.98%
2019 -34.92 47.02%
2018 -23.75 -57.14%
2017 -55.42 -14.92%
2016 -65.13 144.73%
2015 -26.61 375.48%
2014 -5.60 750.36%
2013 -0.66 -27.09%
2012 -0.90 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.48 -1,959.17%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 33.28 -1,843.70%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -1,220.66%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 19.48 -1,120.48%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.16 -2,832.78%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.